felin
infecti
periton
coronaviru
fipv
caus
highli
fatal
diseas
cat
pathogenesi
fip
immun
statu
anim
import
cat
preexist
antibodi
fipv
may
experi
acceler
infect
upon
challeng
result
surviv
time
shorter
seroneg
anim
pedersen
boyl
weiss
scott
phenomenon
refer
earli
death
underli
mechan
thought
antibodydepend
enhanc
infect
macrophag
potterfield
although
antibodi
spike
protein
neutral
viral
infect
vitro
de
groot
et
al
vennema
et
immun
kitten
recombin
vaccinia
viru
express
protein
caus
earli
death
challeng
vennema
et
fipv
virion
contain
three
protein
speci
mol
wt
protein
mol
wt
membran
glycoprotein
mol
wt
nucleocapsid
protein
n
review
spaan
et
al
natur
experiment
fipv
infect
antibodi
found
structur
protein
boyl
et
al
horzinek
et
coronavirus
reprint
request
address
present
address
depart
virolog
faculti
medicin
univers
leiden
demonstr
antibodi
n
may
inhibit
viru
replic
addit
direct
murin
hepat
viru
mhv
system
monoclon
antibodi
n
neutral
infect
vitro
abl
protect
mice
lethal
challeng
found
fleme
et
lecomt
et
protect
also
demonstr
monoclon
antibodi
n
neutral
mhv
vitro
nakanaga
et
al
monoclon
antibodi
protein
transmiss
gastroenter
viru
tgev
swine
neutral
viral
infect
vitro
presenc
complement
wherea
n
fiscu
teramoto
describ
six
antifipv
n
protein
two
antifipv
protein
monoclon
antibodi
fail
neutral
vitro
report
present
cdna
clone
sequenc
analysi
n
protein
gene
fipv
clone
gene
express
use
recombin
vaccinia
viru
system
recombin
use
immun
kitten
subsequ
challeng
fipv
clone
sequenc
fipv
n
gene
prepar
cdna
librari
fipv
genom
rna
describ
de
groot
et
clone
contain
sequenc
deriv
end
genom
identifi
describ
de
groot
et
al
restrict
fragment
clone
de
groot
et
al
subclon
ml
sequenc
use
dideoxi
chain
termin
procedur
anger
eta
comparison
publish
sequenc
onethird
tgev
genom
rasschaert
eta
allow
identif
code
region
n
gene
sequenc
data
analyz
use
comput
program
staden
devereux
et
al
recombin
dna
techniqu
perform
essenti
describ
maniati
er
al
fipv
gene
isol
klenowfil
fragment
reclon
smal
site
vaccinia
viru
insert
vector
chakrabarti
et
al
obtain
dr
b
moss
yield
plasmid
pscfm
site
locat
nucleotid
upstream
translat
initi
codon
mlul
site
locat
nucleotid
downstream
termin
codon
n
gene
isol
noelsphl
fragment
made
bluntend
dna
polymeras
reclon
yield
plasmid
pscfn
fillin
reaction
ndel
site
locat
nucleotid
upstream
initi
codon
n
code
region
restor
aug
codon
read
frame
follow
aug
two
amino
acid
long
termin
upstream
n
gene
sphl
site
locat
nucleotid
downstream
n
gene
termin
codon
restrict
site
underlin
fig
insert
plasmid
pscfm
pscfn
use
construct
recombin
vaccinia
virus
vfm
vfn
respect
use
procedur
describ
chakrabarti
et
control
experi
recombin
vaccinia
viru
vsc
construct
use
recombin
vaccinia
virus
vfm
vfn
vsc
use
immun
kitten
specificpathogenfre
spf
kitten
week
age
inject
subcutan
pfu
second
immun
x
pfu
appropri
viru
given
week
later
two
week
second
immun
kitten
challeng
oral
x
pfu
fipv
strain
examin
daili
clinic
sign
euthanasia
carri
kitten
becam
prostrat
full
postmortem
examin
perform
lysat
fipvinfect
fcwfd
cell
recombin
vaccinia
virusinfect
hela
cell
prepar
metabol
label
l
methionin
radioimmunoprecipit
rip
analysi
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
carri
describ
vennema
et
al
neutral
antibodi
determin
heatinactiv
sera
use
fcwfd
cell
micropl
assay
titer
express
maximum
serum
dilut
inhibit
cytopath
effect
tissu
cultur
infecti
dose
fipv
code
region
n
protein
assign
mrna
respect
de
groot
er
togeth
mrna
mrna
correspond
end
fipv
genom
prepar
cdna
librari
fipv
genom
rna
describ
de
groot
et
clone
contain
sequenc
deriv
end
genom
identifi
coloni
hybrid
use
mrna
probe
de
groot
et
clone
select
sequenc
analysi
sequenc
strategi
shown
fig
addit
cdna
clone
isol
librari
use
fragment
pb
probe
analyz
confirm
nucleotid
sequenc
comparison
publish
sequenc
tgev
region
n
protein
gene
identifi
nucleotid
deriv
amino
acid
sequenc
shown
fig
nucleotid
sequenc
ident
correspond
sequenc
tgev
optim
align
predict
amino
acid
sequenc
repres
graphic
fig
among
protein
sequenc
differ
found
ntermin
region
thought
protrud
viral
membran
n
protein
sequenc
domain
insertionsdelet
multipl
differ
found
around
residu
differ
predominantli
conserv
chang
overal
ident
slightli
lower
n
protein
protein
jacob
et
al
recombin
vaccinia
virus
contain
fipv
n
protein
gene
construct
describ
express
recombin
protein
studi
immunoprecipit
assay
lysat
l
methioninelabel
cell
fig
protein
produc
vfmand
vfninfect
cell
comigr
authent
viral
n
protein
specif
precipit
ascit
fluid
cat
die
fip
recombin
protein
fulli
glycosyl
demonstr
remov
oligosaccharid
side
chain
endoglycosidas
h
data
shown
kitten
immun
recombin
vaccinia
virus
subsequ
challeng
fipv
describ
materi
method
detail
immun
kitten
present
tabl
togeth
surviv
time
challeng
kitten
develop
fever
first
day
return
normal
bodi
temperatur
postchalleng
day
pcd
secondari
pyrexia
start
pcd
except
pcd
pcd
day
pyrexia
reach
kitten
anorect
pcd
onward
fluid
therapi
given
necessari
mortal
curv
challeng
repres
fig
kitten
euthan
week
challeng
group
immun
vsc
vfn
seven
anim
euthan
period
contrast
three
immun
vfm
week
challeng
two
anim
immun
vfm
one
immun
vfn
euthan
postmortem
examin
show
kitten
except
periton
effus
granulomat
lesion
viscera
cat
appar
normal
apart
weight
loss
euthan
pcd
taatccccaccgctggtttcgtncaattaag
mkyillilaciiacvyg
gtgaacgctactgtgccatgcaagacagtggcttgcagtgtatttggcacttctgtccctgctcgtggttcttatggca
erycamqdsglqcingtnsrcqtcfergdliwh
tcttgctaactggaacttcagctggtctgtaatattgattgtttatcagtgatatggccatatggctcgtatcatt
lanwnfswsvilivfitvlqygrpqfswlvygi
aaaatgctgatcatgtu
ctattatggcctagttctagcgcacttgcatactctgtaccgtccatatgttgcggct
kmlimwllwpivlaltifnayseyqvsryvmfgf
ttagtgttgcaggtgcagttgtaacgtttgcactttgwt
svagavvtfalwmmyfvrsvqlyrrtkswwsfn
tcctgagactaatgcaattctttgtgttaatgcattgggtagttatgtgcttcccttatggtactcctacaggtgttacccttactctactca
petnailcvnalgrsyvlpldgtptgvtltl
ggaaatctatatgctgaaggtttcaaaatggctggtggtccatcgagcatgccttacgtcatgctacacctagtaccatcgttt
gnlyaegfkmaggltiehlpkyvmiatpsrtivi
atacattagttggaaaacatgcaactactgccacaggatgggcttactacgttctgctggtttactccaggcacgtact
caatttgagtgaacatgtattagtgtaacta
nlsehekllhmv
matqgqrvnwgdepsk
agacgtggtcgttctaactctcgtggtcggaagaataatgt
rrgrsnsrgrknndiplsfynpitleqgskfwnl
tatgtccgagawccgttcccaaaggaataggtaataacg
cprdlvpkglgnkdqqlgywnrqlryrlvkgqr
taaggaactcgctgawggtggttcttttacrrcttaggtacagcctcatgcttgctttcctggtcttctggggca
kelaerwffyflgtgphadakfkdkidgvfwva
agggatggtgccatgaacacccacaacgcttggcactcgtggcctctccccacttgatggttaccgccacagtc
rdgamnkpttlgtrgtnneskplrfdgkippqfq
levnrsrnnsrsgsqsrsvsrnrsqsrgrhhsn
taaccagaataataatgttgaggatacaattgtagccgtgcttwt
nqnnnvedtivavleklgvtdkqrsrskpr
gattccaaacctagggacacaacacctaagaatgccaaca
dskprdttpknankhtwkktagkgdvttfygar
ssanfgdsdlvangnaakcypqiaecvpsvssi
aatctrrggcagtcaatggtctgctgaagaagctggtcait
ifgsqwsaeeagdqvkvtlthtyylpkddakt
caattcctagaacagattggcttacaaccgaccttctggcctg
qfleqidaykrpsevakdqrqrrsrsksadkkp
intn
ii
ii
ii
tgevm
loo
fpvn
ill
iii
ii
iii
iiiiii
iii
ii
ill
iii
humor
immun
respons
fipv
protein
serum
sampl
taken
day
primari
secondari
immun
day
challeng
differ
pcd
day
euthanasia
petform
aliquot
sera
obtain
anim
recombin
vf
express
fipv
protein
vennema
et
includ
lane
vf
fipv
structur
protein
recombin
vaccinia
viru
express
product
indic
marker
protein
molecular
weight
kilodalton
indic
left
side
one
group
pool
time
point
use
rip
assay
lysat
metabol
label
fipvinfect
cell
amount
pool
antiserum
use
individu
serum
dilut
loofold
final
immunoprecipit
mixtur
pool
sera
day
primari
secondari
immun
gave
background
level
precipit
fig
particularli
nucleocapsid
protein
precipit
nonspecif
probabl
bind
pansorbin
pool
sera
day
challeng
kitten
immun
vfm
vfn
precipit
n
protein
respect
serum
pool
control
group
gave
background
signal
challeng
amount
n
protein
precipit
increas
start
pcd
respect
result
secondari
immun
respons
primari
respons
protein
could
detect
low
level
pcd
pool
sera
vfnimmun
kitten
shortli
challeng
appear
precipit
small
amount
protein
sinc
intens
signal
correl
amount
n
protein
detect
precipit
protein
may
due
format
complex
n
describ
previous
mhv
sturman
et
al
coprecipit
n
protein
antibodi
observ
probabl
background
level
n
precipit
antibodi
structur
protein
increas
high
level
pcd
group
order
find
whether
antibodi
level
surviv
time
correl
kitten
immun
vfm
individu
sera
test
day
secondari
immun
day
challeng
pcd
although
differ
level
antibodi
seen
fig
correl
surviv
time
similarli
small
differ
found
level
antibodi
n
protein
pcd
correl
surviv
time
vitro
neutral
activ
sera
immun
kitten
sera
test
neutral
assay
neutral
activ
detect
pool
sera
pcd
day
sera
delay
complet
inhibit
cpe
pcd
onward
neutral
titer
gradual
increas
similarli
group
x
pcd
differ
observ
vfm
group
two
group
could
advoc
explain
differ
surviv
time
also
among
kitten
vfm
group
small
differ
observ
develop
neutral
titer
respect
time
data
shown
comparison
amino
acid
sequenc
protein
fipv
tgev
reveal
overal
ident
structur
featur
predict
tgev
protein
kapk
et
al
britton
et
also
appli
fipv
interestingli
short
stretch
highli
diverg
amino
acid
sequenc
observ
stretch
amino
acid
residu
signal
sequenc
first
hydrophob
domain
ident
optim
align
nglycosyl
site
three
cystein
residu
locat
region
conserv
analog
mhv
part
protein
predict
expos
outsid
viru
particl
rottier
et
observ
diverg
region
indic
specif
immunolog
pressur
presum
immun
respons
portion
protein
influenc
viru
multipl
data
protein
fipv
ntermin
signal
sequenc
predict
similar
one
found
tgev
britton
et
al
ntermin
signal
sequenc
tgev
protein
absolut
requir
transloc
glycosyl
kapk
eta
howev
remov
small
portion
protein
produc
vitro
translat
presenc
microsom
becam
glycosyl
construct
fipv
gene
lack
signal
se
infect
kitten
fipvspecif
antibodi
detect
use
lysat
metabol
label
fipvinfect
fcwfd
cell
antigen
sourc
panel
vsc
vfm
vfn
pool
sera
eight
kitten
immun
vsc
vfm
vfn
respect
lane
mark
st
repres
reaction
day
first
second
immun
day
challeng
subsequ
number
indic
postchalleng
day
sera
quenc
code
region
express
hela
cell
data
shown
use
hybrid
vaccinia
viru
express
system
fuerst
et
al
mutant
protein
fulli
glycosyl
data
shown
illustr
ntermin
signal
sequenc
fipv
protein
requir
glycosyl
align
n
protein
fipv
tgev
two
diverg
region
may
repres
immunolog
import
domain
n
protein
found
sinc
n
protein
expos
outsid
viru
particl
domain
may
repres
tcell
epitop
rather
bcell
epitop
shown
immun
kitten
fipv
protein
express
live
recombin
vaccinia
viru
made
sensit
challeng
control
anim
vennema
er
show
neither
n
protein
protein
express
recombin
vaccinia
virus
induc
earli
death
challeng
immun
vfn
induc
nprotein
specif
antibodi
kitten
appear
effect
outcom
challeng
contrast
immun
vfm
markedli
affect
surviv
time
challeng
number
kitten
howev
anim
seroconvert
challeng
fig
show
clinic
sign
pyrexia
anorexia
three
eight
anim
recov
infect
clearli
signific
result
need
substanti
addit
immun
experi
serolog
assay
perform
individu
sera
anim
vfmimmun
group
show
correl
antibodi
level
surviv
time
impli
immun
fipv
larg
ceilmedi
pedersen
measur
cellmedi
immun
experiment
infect
cat
report
difficult
perform
show
consider
variat
pedersen
immun
experi
evalu
potenti
role
protein
protect
consid
improv
immunogen
approach
similar
shown
recent
recombin
vaccinia
virusencod
earl
et
demonstr
remov
cryptic
vaccinia
taken
sera
taken
postmortem
kitten
euthan
indic
time
point
includ
pool
closest
time
point
therefor
day
challeng
n
pool
vsc
n
pool
vfm
n
pool
vfn
pcd
n
pool
vfn
pool
n
fig
sdspage
analysi
rip
assay
individu
sera
vfmimmun
group
kitten
immun
vfm
number
shortest
longest
surviv
time
challeng
day
day
day
day
day
sera
day
second
immunizatlon
day
challeng
b
c
day
challeng
panel
c
repres
lower
portion
gel
contain
protein
band
illustr
primari
immun
respons
n
protein
structur
orotein
indic
viru
earli
transcript
termin
signal
mnt
rohrmann
et
enhanc
immunogen
consider
protein
gene
contain
transcript
termin
signal
express
protein
vitro
could
measur
hr
pi
data
shown
although
transcript
driven
gene
earlyl
promot
besid
increas
immunogen
earli
express
essenti
induct
cytotox
tlymphocyt
ctl
recombin
vaccinia
virus
wachsman
et
al
specif
ctl
probabl
major
import
recoveri
fipv
infect
viral
antigen
involv
known
enhanc
induct
ctl
remov
earli
transcript
termin
signal
remain
shown
